Jonathan N. Sachs
Affiliations: | Biomedical Engineering | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Biomedical Engineering, General BiophysicsGoogle:
"Jonathan Sachs"Children
Sign in to add traineeJason D. Perlmutter | grad student | 2011 | UMN |
Christopher C. Valley | grad student | 2012 | UMN |
Anthony R. Braun | grad student | 2014 | UMN |
Andrew Kyle Lewis | grad student | 2015 | UMN (Chemistry Tree) |
Mu Yang | post-doc | 2020- | UMN (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Liao EE, Yang M, Nathan Kochen N, et al. (2023) Proteasomal Stimulation by MK886 and Its Derivatives Can Rescue Tau-Induced Neurite Pathology. Molecular Neurobiology |
Braun AR, Kochen NN, Yuen SL, et al. (2023) Advancements in a FRET Biosensor for Live-Cell Fluorescence-Lifetime High-Throughput Screening of Alpha-Synuclein. Asn Neuro. 15: 17590914231184086 |
Vunnam N, Yang M, Lo CH, et al. (2023) Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling. Acs Bio & Med Chem Au. 3: 270-282 |
Pandey AK, Buchholz CR, Nathan Kochen N, et al. (2023) pH Effects Can Dominate Chemical Shift Perturbations in H,N-HSQC NMR Spectroscopy for Studies of Small Molecule/α-Synuclein Interactions. Acs Chemical Neuroscience |
Ratnapriya S, Braun AR, Cervera Benet H, et al. (2022) Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry. Acs Infectious Diseases |
Nathan Kochen N, Vasandani V, Seaney D, et al. (2022) Threonine Cavities Are Targetable Motifs That Control Alpha-Synuclein Fibril Growth. Acs Chemical Neuroscience |
Braun AR, Liao EE, Horvath M, et al. (2021) Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors. Npj Parkinson's Disease. 7: 52 |
Braun AR, Liao EE, Horvath M, et al. (2021) Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors. Npj Parkinson's Disease. 7: 52 |
Vunnam N, Szymonski S, Hirsova P, et al. (2020) Noncompetitive allosteric antagonism of death receptor 5 by a synthetic affibody ligand. Biochemistry |
Lo CH, Huber EC, Sachs JN. (2020) Conformational states of TNFR1 as a molecular switch for receptor function. Protein Science : a Publication of the Protein Society |